DE3483869D1 - Zusammensetzungen zur bekaempfung von toxaemia. - Google Patents
Zusammensetzungen zur bekaempfung von toxaemia.Info
- Publication number
- DE3483869D1 DE3483869D1 DE8484307227T DE3483869T DE3483869D1 DE 3483869 D1 DE3483869 D1 DE 3483869D1 DE 8484307227 T DE8484307227 T DE 8484307227T DE 3483869 T DE3483869 T DE 3483869T DE 3483869 D1 DE3483869 D1 DE 3483869D1
- Authority
- DE
- Germany
- Prior art keywords
- sup
- combat
- compositions
- toxaemia
- carbon atoms
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 206010004053 Bacterial toxaemia Diseases 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
- 125000000217 alkyl group Chemical group 0.000 abstract 2
- 125000004432 carbon atom Chemical group C* 0.000 abstract 2
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 2
- 241001465754 Metazoa Species 0.000 abstract 1
- 230000001580 bacterial effect Effects 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 239000002095 exotoxin Substances 0.000 abstract 1
- 231100000776 exotoxin Toxicity 0.000 abstract 1
- 239000002636 mycotoxin Substances 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 1
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 1
- 108090000623 proteins and genes Proteins 0.000 abstract 1
- 102000004169 proteins and genes Human genes 0.000 abstract 1
- 231100000331 toxic Toxicity 0.000 abstract 1
- 230000002588 toxic effect Effects 0.000 abstract 1
- 239000002435 venom Substances 0.000 abstract 1
- 231100000611 venom Toxicity 0.000 abstract 1
- 210000001048 venom Anatomy 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/02—Antidotes
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
- C07D285/15—Six-membered rings
- C07D285/16—Thiadiazines; Hydrogenated thiadiazines
- C07D285/18—1,2,4-Thiadiazines; Hydrogenated 1,2,4-thiadiazines
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Epidemiology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Toxicology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Peptides Or Proteins (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB838328111A GB8328111D0 (en) | 1983-10-20 | 1983-10-20 | Chemical compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DE3483869D1 true DE3483869D1 (de) | 1991-02-07 |
Family
ID=10550511
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE19843438469 Withdrawn DE3438469A1 (de) | 1983-10-20 | 1984-10-19 | Mittel zur bekaempfung von toxaemie |
| DE8484307227T Expired - Fee Related DE3483869D1 (de) | 1983-10-20 | 1984-10-19 | Zusammensetzungen zur bekaempfung von toxaemia. |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE19843438469 Withdrawn DE3438469A1 (de) | 1983-10-20 | 1984-10-19 | Mittel zur bekaempfung von toxaemie |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US4626536A (de) |
| EP (1) | EP0139535B1 (de) |
| JP (1) | JPS60105618A (de) |
| AT (1) | ATE59296T1 (de) |
| AU (1) | AU3457384A (de) |
| BE (1) | BE900856A (de) |
| CH (1) | CH660970A5 (de) |
| DE (2) | DE3438469A1 (de) |
| GB (1) | GB8328111D0 (de) |
| IT (1) | IT1178154B (de) |
Families Citing this family (32)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5210083A (en) * | 1986-07-17 | 1993-05-11 | Ed. Geistlich Sohne A.G. Fur Chemische Industrie | Pharmaceutical compositions |
| GB8617482D0 (en) * | 1986-07-17 | 1986-08-28 | Geistlich Soehne Ag | Pharmaceutical composition |
| GB9005856D0 (en) * | 1990-03-15 | 1990-05-09 | Geistlich Soehne Ag | Compositions |
| GB9600426D0 (en) * | 1996-01-10 | 1996-03-13 | Ed Geistlich Sohne A G | Compositions |
| US20050124608A1 (en) * | 2001-04-03 | 2005-06-09 | Redmond H. P. | Treatment of cancers |
| US20060199811A1 (en) * | 1997-07-31 | 2006-09-07 | Pfirrmann Rolf W | Method of treatment for preventing or reducing tumor growth in the liver of patient |
| US6479481B1 (en) * | 1999-06-04 | 2002-11-12 | Ed. Geistlich Soehne Ag Fur Chemische Industrie | Methods and compositions for treating primary and secondary tumors of the central nervous system (CNS) |
| US8304390B2 (en) | 1997-07-31 | 2012-11-06 | Ed. Geistlich Soehne Ag Fuer Chemische Industrie | Method of treatment for preventing or reducing tumor growth in the liver of patient |
| US6011030A (en) * | 1997-09-22 | 2000-01-04 | Ed. Geistlich Sohne Ag Fur Chemische Industrie | Method of treating symptoms of microbial infection or sepsis |
| US5972933A (en) * | 1998-01-08 | 1999-10-26 | Ed. Geistlich Sohne Ag Fur Chemische Industrie | Method of treating microbial infections |
| US6166007A (en) | 1998-07-02 | 2000-12-26 | Sodemann; Klaus | Antimicrobial locks comprising taurinamide derivatives and carboxylic acids and/or salts thereof |
| US7892530B2 (en) | 1999-06-04 | 2011-02-22 | Ed. Geistlich Soehne Ag Fuer Chemische Industrie | Treatment of tumor metastases and cancer |
| US8030301B2 (en) | 1999-06-04 | 2011-10-04 | Ed. Geistlich Soehne Ag Fuer Chemische Industrie | Treatment of cancers with methylol-containing compounds and at least one electrolyte |
| US7345039B2 (en) * | 1999-06-04 | 2008-03-18 | Ed. Geistlich Soehne Ag Fuer Chemische Industrie | Enhancement of effectiveness of 5-fluorouracil in treatment of tumor metastases and cancer |
| US6821968B2 (en) * | 2001-09-26 | 2004-11-23 | Ed. Geistlich Soehne Ag Fuer Chemische Industrie | Stable taurolidine electrolyte solutions |
| US6685694B2 (en) | 1999-07-23 | 2004-02-03 | Vasca, Inc. | Methods and kits for locking and disinfecting implanted catheters |
| US6679870B1 (en) | 1999-07-23 | 2004-01-20 | Vasca, Inc. | Methods and kits for locking and disinfecting implanted catheters |
| JP3213293B2 (ja) | 1999-08-02 | 2001-10-02 | 本田技研工業株式会社 | エンジン制御装置 |
| CN100519525C (zh) * | 1999-12-06 | 2009-07-29 | 葛兰素集团有限公司 | 芳香砜类及其医疗用途 |
| EP1248625A2 (de) * | 1999-12-06 | 2002-10-16 | Rhode Island Hospital | Verwendung von methylol-enthaltenden verbindungen zur herstellung eines medikaments zur behandlung von tumoren |
| US20020004502A1 (en) | 2000-01-05 | 2002-01-10 | Redmond H. Paul | Treatment of inflammatory bowel disease |
| US6641571B2 (en) | 2000-01-05 | 2003-11-04 | Ed. Geistlich Soehne Ag Fuer Chemische Industrie | Reduction of postoperative complications of cardiopulmonary bypass (CPB) surgery |
| EP1245247A1 (de) | 2001-03-28 | 2002-10-02 | Biolink Corporation | Biozidschleuse |
| US20080171738A1 (en) * | 2001-04-03 | 2008-07-17 | Ed. Geistlich Soehne Ag Fuer Chemische Industrie | Treatment of Breast Cancer |
| US6753328B2 (en) | 2001-10-01 | 2004-06-22 | Rhode Island Hospital | Methods of inhibiting metastases |
| US20050008684A1 (en) * | 2003-07-10 | 2005-01-13 | Claus Herdeis | Method of treatment for acne, rosacea and ulcers with taurolidine and/or taurultam in a pharmaceutical composition |
| WO2005115357A2 (en) * | 2004-05-14 | 2005-12-08 | Hans-Dietrich Polaschegg | Taurolidine formulations and delivery |
| US7696182B2 (en) | 2004-11-02 | 2010-04-13 | Nd Partners, Llc | Antimicrobial locking solutions comprising taurinamide derivatives and biologically acceptable salts and acids, with the addition of small concentrations of heparin |
| RU2624846C1 (ru) * | 2016-10-10 | 2017-07-07 | федеральное государственное бюджетное учреждение "Федеральный научно-исследовательский центр эпидемиологии и микробиологии имени почетного академика Н.Ф. Гамалеи" Министерства здравоохранения Российской Федерации | Применение 4-(3-этокси-4-гидроксибензил)-5-оксо-5,6-дигидро-4Н-[1,3,4]-тиадиазин-2-(2,4-дифторфенил)-карбоксамида для подавления инфекции, вызванной устойчивыми к антибиотикам штаммами Pseudomonas aeruginosa, и способ подавления этой инфекции |
| CA3086396A1 (en) | 2017-12-21 | 2019-06-27 | Cormedix Inc. | Methods and pharmaceutical compositions for treating candida auris in blood |
| RU2737087C1 (ru) * | 2020-03-20 | 2020-11-24 | федеральное государственное бюджетное учреждение «Национальный исследовательский центр эпидемиологии и микробиологии имени почетного академика Н.Ф. Гамалеи» Министерства здравоохранения Российской Федерации | Фармацевтическая композиция 4-(3-этокси-4-гидроксибензил)-5-оксо-5,6-дигидро-4h-[1,3,4]-тиадиазин-2-(2,4-дифторфенил)"карбоксамид в кристаллической форме, и ее применение в качестве антибактериального препарата для лечения острых, рецидивирующих и хронических инфекций |
| US11738120B1 (en) | 2022-04-14 | 2023-08-29 | Cormedix Inc. | Synthesis of taurolidine, purity profiles and polymorphs |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1525296A (en) * | 1975-08-04 | 1978-09-20 | Geistlich Soehne Ag | Antibacterial compositions |
| US4107305A (en) * | 1975-08-04 | 1978-08-15 | Ed. Geistlich Sohne A.G. Fur Chemische Industrie | Treatment of endotoxaemia |
-
1983
- 1983-10-20 GB GB838328111A patent/GB8328111D0/en active Pending
-
1984
- 1984-10-18 IT IT49031/84A patent/IT1178154B/it active
- 1984-10-19 BE BE0/213859A patent/BE900856A/fr not_active IP Right Cessation
- 1984-10-19 DE DE19843438469 patent/DE3438469A1/de not_active Withdrawn
- 1984-10-19 EP EP84307227A patent/EP0139535B1/de not_active Expired - Lifetime
- 1984-10-19 CH CH5035/84A patent/CH660970A5/de not_active IP Right Cessation
- 1984-10-19 DE DE8484307227T patent/DE3483869D1/de not_active Expired - Fee Related
- 1984-10-19 JP JP59218751A patent/JPS60105618A/ja active Pending
- 1984-10-19 AT AT84307227T patent/ATE59296T1/de not_active IP Right Cessation
- 1984-10-19 US US06/662,887 patent/US4626536A/en not_active Expired - Lifetime
- 1984-10-22 AU AU34573/84A patent/AU3457384A/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| GB8328111D0 (en) | 1983-11-23 |
| JPS60105618A (ja) | 1985-06-11 |
| US4626536A (en) | 1986-12-02 |
| CH660970A5 (de) | 1987-06-30 |
| AU3457384A (en) | 1986-04-24 |
| IT8449031A1 (it) | 1986-04-18 |
| EP0139535A3 (en) | 1985-10-23 |
| IT1178154B (it) | 1987-09-09 |
| EP0139535A2 (de) | 1985-05-02 |
| IT8449031A0 (it) | 1984-10-18 |
| DE3438469A1 (de) | 1985-05-09 |
| BE900856A (fr) | 1985-02-15 |
| EP0139535B1 (de) | 1990-12-27 |
| ATE59296T1 (de) | 1991-01-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE3483869D1 (de) | Zusammensetzungen zur bekaempfung von toxaemia. | |
| ES2065880T3 (es) | Proteina quimicamente modificada y obtencion de la misma. | |
| AU600688B2 (en) | Insecticidal pyrazolines | |
| ATE89731T1 (de) | Zusammensetzungen zur propylaktischen behandlung von osteitis und osteomyelitis. | |
| FR2515179B1 (de) | ||
| DE59002863D1 (de) | Lysolecithinderivate zur behandlung von autoimmunerkrankungen. | |
| ES8505374A1 (es) | Un procedimiento para la preparacion de un derivado de cefalosporina | |
| AU1395283A (en) | 1-carboxyalkanoylindoline-2-carboxylic acid esters | |
| ATE48001T1 (de) | Cephemverbindungen, verfahren zu ihrer herstellung und ihre pharmazeutischen praeparate. | |
| DK288686A (da) | Farmaceutiske praeparater | |
| GR3035205T3 (en) | Compounds related to the amidinium family, pharmaceutical compositions containing same, and uses thereof | |
| JPS5547668A (en) | Epoxysuccinamic acid | |
| EA200001107A1 (ru) | ПРОИЗВОДНЫЕ ОКТАГИДРО-6,10-ДИОКСО-6H-ПИРИДАЗИНО [1,2-a] [1,2] ДИАЗЕПИН-1-КАРБОНОВОЙ КИСЛОТЫ, СПОСОБ ПОЛУЧЕНИЯ И ИХ ПРИМЕНЕНИЕ ДЛЯ ПОЛУЧЕНИЯ ТЕРАПЕВТИЧЕСКИ АКТИВНЫХ СОЕДИНЕНИЙ | |
| ES8300096A1 (es) | "un procedimiento para preparar derivados de halofenil-piridil-alilamina". | |
| AU557068B2 (en) | 1-aroyl-5-oxo-2-pyrrolidine propanoic acids and esters | |
| DK159649C (da) | 4-hydroxy-alfa-benzhydrolderivater, fremgangsmaade til fremstilling deraf, farmaceutiske praeparater indeholdende disse, samt fremgangsmaade til fremstilling af disse farmaceutiske praeparater | |
| ATE19472T1 (de) | Verwendung von 5-phenyl-1,4-benzodoazepinen zur herstellung von analgetisch wirksamen pharmazeutischen zubereitungen. | |
| ATE33139T1 (de) | Oximinophosphorsaeurederivate, verfahren zu ihrer herstellung und ihre verwendung zur bekaempfung von schaedlingen. | |
| EP0086756A3 (de) | Dermatologische Mittel die auf Thiolester der Merkaptopropionylamidoessigsäure basieren | |
| NZ334634A (en) | Use of a protein extracted from mammalian liver for treating HIV | |
| IE880226L (en) | 2-(2,2-difluorocyclopropyl) alkyl esters | |
| DE3766028D1 (de) | 1-hydroxy-5-oxo-5h-pyrido(3,2-a)-phenoxazin-3-carbonsaeureester. | |
| KR900003162A (ko) | 비스(메틸렌디옥시)비페닐 화합물 | |
| WO1987003596A3 (fr) | Nouveaux composes phosphores et medicaments les contenant |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 8364 | No opposition during term of opposition | ||
| 8339 | Ceased/non-payment of the annual fee |